Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

BNS

Unpacking BNS Stock – Key Benefits for Investors

It hasn't been a great afternoon session for Bank of Nova Scotia investors, who have watched their shares sink by -1.6% to a price of $50.88. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

Bank of Nova Scotia's Earnings and Assets May Be Undervalued:

The Bank of Nova Scotia provides various banking products and services in Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean and Central America, and internationally. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 20.04 and an average price to book (P/B) ratio of 1.86. In contrast, Bank of Nova Scotia has a trailing 12 month P/E ratio of 12.5 and a P/B ratio of 0.77.

Bank of Nova Scotia has moved 11.0% over the last year compared to 23.6% for the S&P 500 — a difference of -12.7%. Bank of Nova Scotia has a 52 week high of $57.07 and a 52 week low of $43.68.

A Declining EPS Growth Trend and Positive Cash Flows:

2019 2020 2021 2022 2023 2024
Revenue (M) $7,968 $7,505 $7,687 $7,626 $8,272 $8,364
Interest Income (M) $3,916 $2,394 $1,969 $6,496 $10,443 $10,821
Net Margins 28% 25% 33% 27% 16% 23%
Net Income (M) $2,308 $1,899 $2,559 $2,093 $1,354 $1,912
Depreciation & Amort. (M) $271 $407 $383 $394 $590 $428
Earnings Per Share $1.73 $1.42 $1.97 $1.63 $0.99 $1.41
EPS Growth n/a -17.92% 38.73% -17.26% -39.26% 42.42%
Free Cash Flow (M) -$12,025 $56,664 -$12,807 $16,943 $31,724 $7,113
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS